|
⚲
|
| Keyboard |
| Humphrey Rachel
✚
|
|
|---|---|
| CIK # | 0001579781 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001579781] | |
| 4 | [0001579781] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Humphrey Rachel | |
| Pyxis Oncology Inc | |
| Xilio Therapeutics Inc | |
| Black Diamond Therapeutics Inc | |
| CytomX Therapeutics Inc | |
| Mirati Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2026-03-24 | Grant | 45,867 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2025-04-21 | Sell | 13,896 | $1.03 | 14,313 |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2025-04-17 | Sell | 200 | $0.97 | 194 |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2025-04-14 | Sell | 1,400 | $0.97 | 1,358 |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Grant | 36,979 | $0.98 | 36,239 |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2024-03-26 | Grant | 38,741 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2023-03-24 | Grant | 58,064 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2022-08-11 | Grant | 236,220 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2021-02-17 | Grant | 60,000 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Common Stock
|
2020-09-08 | Grant | 10,000 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2020-09-08 | Grant | 150,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Stock Option (right to buy) · derivative
|
2019-01-25 | Grant | 90,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2018-03-02 | Sell | 16,160 | $30.00 | 484,800 |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2018-03-02 | Option exercise | 16,160 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2018-03-02 | Option exercise | 16,160 | $6.61 | 106,818 |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2018-02-28 | Sell | 23,840 | $30.00 | 715,200 |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2018-02-28 | Option exercise | 23,840 | $6.61 | 157,582 |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2018-02-28 | Option exercise | 23,840 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Stock Option (right to buy) · derivative
|
2018-01-24 | Grant | 100,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2017-12-15 | Option exercise | 15,117 | $6.61 | 99,923 |
| showing 20 of 25 most recent transactions | |||||